Search

everythinglearnresearchcommunity

for

Search:↓

Using a call center to collect data in a trial for eye disease in diabetics led to high response rates and very little missing information.

The goal is to create a tool for patients to report their experiences with various hair and scalp disorders.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Photobiomodulation therapy may speed up hair regrowth after chemotherapy in the short term.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Clascoterone is safe for the heart, even at high doses.

RCS-01 cell therapy is safe and improves skin gene expression.

The study aims to find the best platelet-rich plasma dose to relieve moderate carpal tunnel syndrome symptoms.

Topical GT20029 effectively promotes hair regrowth and is well-tolerated.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Personalized sonidegib dosing can effectively treat Gorlin-Goltz syndrome with fewer side effects.

PRP injections with tadalafil and stretching safely improved Peyronie's symptoms but didn't significantly change curvature long-term.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

The treatment is safe and shows promise for metastatic breast cancer.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.